470 related articles for article (PubMed ID: 19565507)
1. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways.
Trouw LA; Haisma EM; Levarht EW; van der Woude D; Ioan-Facsinay A; Daha MR; Huizinga TW; Toes RE
Arthritis Rheum; 2009 Jul; 60(7):1923-31. PubMed ID: 19565507
[TBL] [Abstract][Full Text] [Related]
2. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
3. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts.
Lee HS; Irigoyen P; Kern M; Lee A; Batliwalla F; Khalili H; Wolfe F; Lum RF; Massarotti E; Weisman M; Bombardier C; Karlson EW; Criswell LA; Vlietinck R; Gregersen PK
Arthritis Rheum; 2007 Jun; 56(6):1745-53. PubMed ID: 17530703
[TBL] [Abstract][Full Text] [Related]
4. Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis.
Inui N; Enomoto N; Suda T; Kageyama Y; Watanabe H; Chida K
Clin Biochem; 2008 Sep; 41(13):1074-7. PubMed ID: 18638466
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to viral citrullinated peptide in rheumatoid arthritis.
Anzilotti C; Merlini G; Pratesi F; Tommasi C; Chimenti D; Migliorini P
J Rheumatol; 2006 Apr; 33(4):647-51. PubMed ID: 16511941
[TBL] [Abstract][Full Text] [Related]
6. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark.
Pedersen M; Jacobsen S; Garred P; Madsen HO; Klarlund M; Svejgaard A; Pedersen BV; Wohlfahrt J; Frisch M
Arthritis Rheum; 2007 May; 56(5):1446-53. PubMed ID: 17469102
[TBL] [Abstract][Full Text] [Related]
7. Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis.
Shibata S; Tada Y; Komine M; Hattori N; Osame S; Kanda N; Watanabe S; Saeki H; Tamaki K
J Dermatol Sci; 2009 Jan; 53(1):34-9. PubMed ID: 18752933
[TBL] [Abstract][Full Text] [Related]
8. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue.
Vossenaar ER; Smeets TJ; Kraan MC; Raats JM; van Venrooij WJ; Tak PP
Arthritis Rheum; 2004 Nov; 50(11):3485-94. PubMed ID: 15529392
[TBL] [Abstract][Full Text] [Related]
9. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis.
van Oosterhout M; Bajema I; Levarht EW; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2008 Jan; 58(1):53-60. PubMed ID: 18163491
[TBL] [Abstract][Full Text] [Related]
10. IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
Vis M; Bos WH; Wolbink G; Voskuyl AE; Twisk JW; Van de Stadt R; Hamann D; Dijkmans BA; Lems WF
J Rheumatol; 2008 Mar; 35(3):425-8. PubMed ID: 18322974
[TBL] [Abstract][Full Text] [Related]
11. Insights to clinical use of serial determination in titers of cyclic citrullinated peptide autoantibodies.
Kogure T; Tatsumi T; Fujinaga H; Niizawa A; Terasawa K
Mediators Inflamm; 2007; 2007():12367. PubMed ID: 17497027
[TBL] [Abstract][Full Text] [Related]
12. The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels.
Bos WH; Ursum J; de Vries N; Bartelds GM; Wolbink GJ; Nurmohamed MT; van der Horst-Bruinsma IE; van de Stadt RJ; Crusius JB; Tak PP; Dijkmans BA; van Schaardenburg D
Ann Rheum Dis; 2008 Sep; 67(9):1347-50. PubMed ID: 18388157
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and significance of antibodies to citrullinated human papilloma virus-47 E2345-362 in rheumatoid arthritis.
Shi J; Sun X; Zhao Y; Zhao J; Li Z
J Autoimmun; 2008 Sep; 31(2):131-5. PubMed ID: 18511237
[TBL] [Abstract][Full Text] [Related]
14. IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA.
Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
Rheumatology (Oxford); 2008 Oct; 47(10):1489-92. PubMed ID: 18703528
[TBL] [Abstract][Full Text] [Related]
15. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis.
Pratesi F; Tommasi C; Anzilotti C; Chimenti D; Migliorini P
Arthritis Rheum; 2006 Mar; 54(3):733-41. PubMed ID: 16508937
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
17. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis and the complement system.
Okroj M; Heinegård D; Holmdahl R; Blom AM
Ann Med; 2007; 39(7):517-30. PubMed ID: 17852027
[TBL] [Abstract][Full Text] [Related]
19. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
[TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
Habib HM; Mosaad YM; Youssef HM
Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
